Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
Antonio Dominguez‐Meijide, Valeria Parrales, Eftychia Vasili, Florencia González‐Lizárraga, Annekatrin König, Diana F. Lázaro, Annie Lannuzel, Stéphane Haı̈k, Elaine Aparecida Del Bel, Rosana Nieves Chehín, Rita Raisman‐Vozari, Patrick Pierre Michel, Nicolas Bizat, Tiago F. Outeiro
This study shows doxycycline reduces α-synuclein aggregation and oxidative stress in vitro and in vivo, suggesting it could treat synucleinopathies like Parkinson's disease.
Neurobiology of Disease · Jan 12, 2021Peer-reviewedMolecular Biology